Clinically Actionable Tumor-Associated Antigens in Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Metastatic Prostate Cancer
Related studies linked through entity extraction aliases.
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian Cohort
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pharmaceutical Management in Targeted Radioligand Therapy
- Status
- RECRUITING
- Phase
- N/A
Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)
- Status
- RECRUITING
- Phase
- N/A
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
- Status
- RECRUITING
- Phase
- PHASE4
Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Physician- and Patient-based Barriers to NGS Testing
- Status
- RECRUITING
- Phase
- NA
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients
- Status
- RECRUITING
- Phase
- NA
A Study of Tarlatamab for People With Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2